HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nickel nanoparticles cause exaggerated lung and airway remodeling in mice lacking the T-box transcription factor, TBX21 (T-bet).

AbstractBACKGROUND:
Nickel nanoparticles (NiNPs) are increasingly used in a variety of industrial applications, including the manufacturing of multi-walled carbon nanotubes (MWCNTs). While occupational nickel exposure is a known cause of pulmonary alveolitis, fibrosis, and cancer, the health risks of NiNPs are not well understood, especially in susceptible individuals such as asthmatics. The T-box transcription factor Tbx21 (T-bet) maintains Th1 cell development and loss of T-bet is associated with a shift towards Th2 type allergic airway inflammation that characterizes asthma. The purpose of this study was to determine the role of T-bet in susceptibility to lung remodeling by NiNPs or MWCNTs.
METHODS:
Wild-type (WT) and T-bet-/- mice were exposed to NiNPs or MWCNTs (4 mg/kg) by oropharyngeal aspiration (OPA). Necropsy was performed at 1 and 21 days. Bronchoalveolar lavage fluid (BALF) was collected for differential counting of inflammatory cells and for measurement of cytokines by ELISA. The left lung was collected for histopathology. The right lung was analyzed for cytokine or mucin (MUC5AC and MUC5B) mRNAs.
RESULTS:
Morphometry of alcian-blue/periodic acid Schiff (AB/PAS)-stained lung tissue showed that NiNPs significantly increased mucous cell metaplasia in T-bet-/- mice at 21 days (p < 0.001) compared to WT mice, and increased MUC5AC and MUC5B mRNAs (p < 0.05). MWCNTs also increased mucous cell metaplasia in T-bet-/- mice, but to a lesser extent than NiNPs. Chronic alveolitis was also increased by NiNPs, but not MWCNTs, in T-bet-/- mice compared to WT mice at 21 days (P < 0.001). NiNPs also increased IL-13 and eosinophils (p < 0.001) in BALF from T-bet-/- mice after 1 day. Interestingly, the chemokine CCL2 in the BALF of T-bet-/- mice was increased at 1 and 21 days (p < 0.001 and p < 0.05, respectively) by NiNPs, and to a lesser extent by MWCNTs at 1 day. Treatment of T-bet-/- mice with a monoclonal anti-CCL2 antibody enhanced NiNP-induced mucous cell metaplasia and MUC5AC mRNA levels (p < 0.05), yet marginally reduced NiNP-induced alveolitis.
CONCLUSION:
These findings identify T-bet as a potentially important susceptibility factor for NiNP exposure and to a lesser extent for MWCNT exposure, and suggests that individuals with asthma are at greater risk.
AuthorsEllen E Glista-Baker, Alexia J Taylor, Brian C Sayers, Elizabeth A Thompson, James C Bonner
JournalParticle and fibre toxicology (Part Fibre Toxicol) Vol. 11 Pg. 7 (Feb 06 2014) ISSN: 1743-8977 [Electronic] England
PMID24499286 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • Chemokine CCL2
  • Muc5ac protein, mouse
  • Muc5b protein, mouse
  • Mucin 5AC
  • Mucin-5B
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • Nickel
  • Collagen
Topics
  • Airway Remodeling (drug effects)
  • Animals
  • Antibodies, Blocking (pharmacology)
  • Antibodies, Monoclonal (pharmacology)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Chemokine CCL2 (antagonists & inhibitors, biosynthesis, genetics)
  • Collagen (metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • Fibrosis (pathology)
  • Lung (pathology)
  • Lung Diseases (chemically induced, pathology)
  • Male
  • Metal Nanoparticles (toxicity)
  • Metaplasia (pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mucin 5AC (genetics)
  • Mucin-5B (genetics)
  • Nickel (toxicity)
  • Pulmonary Eosinophilia (pathology)
  • Pulmonary Fibrosis (chemically induced, pathology)
  • Real-Time Polymerase Chain Reaction
  • T-Box Domain Proteins (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: